Biomaterial-based in vitro 3D modeling of glioblastoma multiforme
Cancer Pathogenesis and Therapy · 2023-07 · 1 (3) · 177-194
DOI: 10.1016/j.cpt.2023.01.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Pathogenesis and Therapy, 2023-07. Verfasst von Tanvir Ahmed. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, North South University, Bashundhara, Dhaka, 1229, Bangladesh. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 280 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Adult-onset brain cancers, such as glioblastomas, are particularly lethal. People with glioblastoma multiforme (GBM) do not anticipate living for more than 15 months if there is no cure. The results of conventional treatments over the past 20 years have been underwhelming. Tumor aggressiveness, location, and lack of systemic therapies that can penetrate the blood-brain barrier are all contributing factors. For GBM treatments that appear promising in preclinical studies, there is a considerable rate of failure in phase I and II clinical trials. Unfortunately, access becomes impossible due to the intricate architecture of tumors. In vitro, bioengineered cancer models are currently being used by researchers to study disease development, test novel therapies, and advance specialized medications. Many different techniques for creating in vitro systems have arisen over the past few decades due to developments in cellular and tissue engineering. Later-stage research may yield better results if in vitro models that resemble brain tissue and the blood-brain barrier are used. With the use of 3D preclinical models made available by biomaterials, researchers have discovered that it is possible to overcome these limitations. Innovative in vitro models for the treatment of GBM are possible using biomaterials and novel drug carriers. This review discusses the benefits and drawbacks of 3D in vitro glioblastoma modeling systems.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, North South University, Bashundhara, Dhaka, 1229, Bangladesh.
Zitieren
APA
Ahmed, T. (2023). Biomaterial-based in vitro 3D modeling of glioblastoma multiforme. Cancer Pathogenesis and Therapy, 1(3), 177-194. https://doi.org/10.1016/j.cpt.2023.01.002
Vancouver
Ahmed T. Biomaterial-based in vitro 3D modeling of glioblastoma multiforme. Cancer Pathogenesis and Therapy. 2023;1(3):177-194. doi:10.1016/j.cpt.2023.01.002
BibTeX
@article{Ahmed2023,
author = {Ahmed, Tanvir},
title = {Biomaterial-based in vitro 3D modeling of glioblastoma multiforme},
journal = {Cancer Pathogenesis and Therapy},
year = {2023},
volume = {1},
number = {3},
pages = {177--194},
doi = {10.1016/j.cpt.2023.01.002}
}
EUVIMED